United Therapeutics Correlations
UTHR Stock | USD 312.99 0.61 0.19% |
The current 90-days correlation between United Therapeutics and Incyte is -0.02 (i.e., Good diversification). The correlation of United Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
United Therapeutics Correlation With Market
Significant diversification
The correlation between United Therapeutics and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
United |
Moving together with United Stock
Moving against United Stock
0.63 | PG | Procter Gamble | PairCorr |
0.41 | WM | Waste Management | PairCorr |
0.38 | LUCD | Lucid Diagnostics | PairCorr |
0.6 | JNJ | Johnson Johnson | PairCorr |
0.52 | T | ATT Inc Earnings Call Today | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between United Stock performing well and United Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze United Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INCY | 1.43 | (0.12) | 0.00 | (0.48) | 0.00 | 2.63 | 12.72 | |||
ALNY | 1.94 | 0.32 | 0.15 | 0.22 | 1.88 | 4.69 | 15.40 | |||
RARE | 1.93 | (0.19) | 0.00 | 0.54 | 0.00 | 4.02 | 11.45 | |||
APLS | 2.14 | (0.37) | 0.00 | (0.43) | 0.00 | 4.11 | 20.77 | |||
REPL | 2.83 | (0.06) | 0.00 | (0.11) | 0.00 | 5.86 | 22.75 | |||
NUVL | 2.08 | (0.10) | 0.00 | 1.13 | 0.00 | 3.54 | 12.24 | |||
VTYX | 3.35 | (0.63) | 0.00 | (0.46) | 0.00 | 6.88 | 27.07 | |||
ASND | 2.44 | 0.29 | 0.16 | (0.65) | 2.25 | 5.86 | 18.15 | |||
MNKD | 1.83 | (0.26) | 0.00 | (0.37) | 0.00 | 2.72 | 13.20 | |||
LRMR | 3.79 | (1.03) | 0.00 | (0.47) | 0.00 | 6.61 | 21.96 |
United Therapeutics Corporate Management
Holly Hobson | Associate Resources | Profile | |
JD MBA | Chairman Founder | Profile | |
Gil Golden | Senior Officer | Profile | |
Dewey CFA | Head Relations | Profile | |
Kevin Gray | Senior Logistics | Profile |